Which One Is The ‘Killer’ Altcoin For December
As December approaches, traders are actively looking for the next altcoin that will bring them incredible profits. Among these contenders, DTX Exchange (DTX), Injective (INJ), and Sui Blockchain (SUI) are vying for attention. Each project has its unique advantages, but DTX Exchange stands out as a hybrid trading platform ready to redefine the trading experience.
But should investors consider DTX Exchange as their top investment choice in December, ahead of Sui and INJ? Let’s take a look.
Injective (INJ) surges 23%: AI-powered ‘iAgent’ fuels token surge
Injective (INJ) recently launched a new software package that allows anyone to create their own artificial intelligence agents on the blockchain. The tool, called iAgent, aims to make using blockchain easier by adding artificial intelligence to help users regardless of their skill level. iAgent will simplify interactions by providing AI-driven prompts and guidance.
The announcement caught the attention of investors, causing Injective’s token INJ to surge 23% over the past week. Looking ahead, interest in the token is expected to remain strong due to excitement around artificial intelligence and new software suites. Therefore, experts believe that INJ may continue to grow next month.
Sui Blockchain Back Online: Will SUI Price Rebound from the Decline?
Sui Blockchain encountered a major issue last week when it stopped generating new blocks for approximately two and a half hours. The issue is caused by an update designed to improve network functionality. A flaw in this update caused problems, but the development team acted quickly and released a fix to resolve the issue.
Currently, SUI is trading around $3.23, down 11% over the past week, likely affected by recent network issues. However, it was up 95% last month and 460% since November 2023. Sui Blockchain has a daily trading volume of $2.41 billion and remains popular with investors. The swift response from the development team seemed to reassure many, which is expected to maintain strong buying interest in the coin and increase its price.
DTX Presale: Secure your token before 100x surge at $0.10
While Injective and Sui Blockchain may each have their merits, DTX Exchange is expected to stand out this December and beyond. What truly sets DTX Exchange apart is its innovative hybrid approach. The model addresses key issues affecting the trading industry, including limited access, high fees, and a lack of diverse asset classes.
and, DTX Exchange Committed to promoting financial inclusion. The platform enables individuals to have limited access to the formal banking system by allowing users to transact directly from crypto wallets without the need for a traditional bank account. This approach is significant as it opens the door for countless users to participate in global financial markets, thereby democratizing transactions.
As a pre-sale token, the DTX token is currently undervalued, especially compared to other top altcoins. In the fifth public pre-sale, the token was priced at just $0.10 and is expected to achieve a 100-fold increase upon listing on primary exchanges. Having raised nearly $9 million in early funding and pre-listed on CoinMarketCap, DTX is undoubtedly one of the new altcoins to watch this December.
learn more:
